Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)

NCT05547815 is registered in ClinicalTrials.gov with Changchun Zhuoyi Biological Co., Ltd as lead sponsor.

NCT NCT05547815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05547815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm, Single Center Phase IV Clinical Trial to Evaluate the Immune Persistence and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell)
Lead sponsor
Changchun Zhuoyi Biological Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
November 11, 2019
Completion date
November 8, 2021
Enrollment
149 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody, rabies